Dr. Maulik Manharlal Dhandha, MD

Dr. Dhandha practices at Pacific Skin Institute in Sacramento, California.

Dr. Dhandha's NPI, 1972946366, was assigned on April 16, 2013. Dr. Dhandha graduated from Saint Louis University School Of Medicine in 2013. Dr. Dhandha's California license number on file is A175293.

Dr. Dhandha's primary practice is Pacific Skin Institute, at 1495 River Park Dr, Sacramento, CA 95815 in Sacramento County. The practice phone is (916) 925-7020.

Dr. Dhandha's primary practice is Pacific Skin Institute in Sacramento, California. The medical group on file is Pacific Skin Institute. Dmand AI also links Dr. Dhandha to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dhandha practices. Vendor and product names are available with a free account.

Dermatology is Dr. Dhandha's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dhandha is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Dhandha's licenses on file in 4 states: California, Maine, Missouri and Illinois.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, itchy rashes, psoriasis and rash among the conditions Dr. Dhandha treats.

CMS data shows 1,262 Medicare services from Dr. Dhandha across 13 procedure codes in 2024, for 333 Medicare patients. Medicare paid $68,677 for them. Every service was in an office.

CMS counts 333 Medicare patients who saw Dr. Dhandha in 2024. The largest group is 65 to 74, with 143 patients. 67% of them have high blood pressure, and 65% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dhandha's median patient age at 46, with 58% women.

In 2024, Dr. Dhandha wrote 972 Medicare Part D claims for 332 patients. 83% of them were for generic drugs. CMS names the drug for 841 of them, across 18 drugs with 11 or more claims each, at $411,141 in total drug cost. In 2023, CMS named 690 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Dhandha for performance year 2024, reported through an alternative payment model (APM). Dr. Dhandha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dhandha as offering telehealth. CMS counts 1,065 procedures of removal of skin lesions by Dr. Dhandha, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 19 papers to Dr. Dhandha, published from 2011 to 2023. 2012 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Antibodies, Monoclonal and Diagnosis, Differential. Dr. Dhandha has published most often in BMJ Case Rep. Dr. Dhandha's most frequent co-authors are Alexander Vernon Fisher, MD, Mark Joseph Fesler, MD and Scott William Fosko, MD.

CMS Open Payments shows 184 general payments to Dr. Dhandha from 19 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 38% of the total. Sanofi and Genzyme US Companies paid the most, $10,149.

Dr. Dhandha graduated from Saint Louis University School Of Medicine in 2013.

Dr. Dhandha is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.